Revugam 50mg Tablet
Marketer
Bharat Serums & Vaccines Ltd
Salt Composition
Eltrombopag (50mg)
Overview Revugam 50mg Tablet
Eltrombopag 50mg tablets are indicated for the management of low platelet counts stemming from chronic immune thrombocytopenic purpura (ITP) or chronic hepatitis C (HCV) infection. This medication also treats severe aplastic anemia. Acting as a thrombopoietin receptor agonist, eltrombopag stimulates platelet production, thereby aiding in hemostasis. Adhere strictly to your physician's prescribed dosage and regimen. It can be taken on an empty stomach and should be swallowed whole; avoid crushing, chewing, or breaking the tablet. Report any known drug allergies to your doctor. Common adverse reactions may include nausea, vomiting, diarrhea, upper respiratory infection, and urinary tract infection. Consult your physician if these side effects are troublesome; management strategies may be available. Prior to commencing treatment, disclose any existing health conditions and all other medications currently in use. Dose modifications might be necessary for individuals with hepatic impairment; inform your doctor accordingly.
Uses of Revugam 50mg Tablet
Thrombocytopenia from immune thrombocytopenic purpura or hepatitis C; managing severe aplastic anemia.
Major Benefits of Revugam 50mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Revugam 50mg Tablet on an empty stomach.
Common Side effects of Revugam 50mg Tablet:
- Nausea
- Diarrhea
- Upper respiratory tract infection
- Vomiting
- Increased liver enzymes
- Muscle pain
- Urinary tract infection
How to use Revugam 50mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Revugam 50mg Tablet on an empty stomach.
How Revugam 50mg Tablet works:
Trombopoietin receptor agonist Revugam (50mg tablets) promotes platelet production, thereby mitigating or preventing hemorrhaging.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Revugam 50mg Tablet lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Using Revugam 50mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the unborn. A physician will assess the advantages against potential hazards before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Revugam 50mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving may be impaired by Revugam 50mg Tablet, which can induce dizziness and other side effects that reduce alertness.
KidneySAFE IF PRESCRIBED
Revugam 50mg tablets can be used safely by individuals with kidney disease; dosage modification isn't necessary. Nevertheless, disclose any kidney condition to your physician. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Revugam 50mg tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Revugam 50mg Tablet :
Omit any missed Revugam 50mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Revugam 50mg Tablet
| Label | Value |
|---|---|
| Type of Compound | Diphenyl compounds |
| Potential for Dependence | None. |
| Medication Classification | Hematological |
| Mechanism of Action | Stimulator of thrombopoiesis |
3,018 People bought this recently
